Expired CME Article

Complications of Influenza

Authors: Fares Khater, MD, Jonathan P. Moorman, MD

Abstract

The clinical course of influenza may be characterized by complications that include not only lower respiratory tract infections but also nonrespiratory manifestations. The mechanisms by which influenza induces many of these complications remain for the most part unclear. The most frequent complications are shown in Table 1.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Louria DB, Blumfeld JL, Ellis JT. Studies on influenza in the pandemic of 1957–1958: Part II—Pulmonary complications of influenza. J Clin Invest 1959; 38: 213–265.
 
2. Greenberg SB. Viral pneumonia. Infect Dis Clin North Am 1991; 5: 603–621.
 
3. Ison MG, Hayden FG. Therapeutic options for the management of influenza. Curr Opin Pharmacol 2001; 1: 482–490.
 
4. Winterbauer RH, Ludwig WR, Hammar SP. Clinical course, management, and long-term sequelae of respiratory failure due to influenza viral pneumonia. Johns Hopkins Med J 1977; 141: 148–155.
 
5. Laraya-Cuasay LR, DeForest A, Huff D, et al. Chronic pulmonary complications of early influenza virus infection in children. Am Rev Respir Dis 1977; 116: 617–625.
 
6. Wright PF, Webster RG. Orthomyxoviruses, in Knipe DM, Howley PM, Griffin DE, et al (eds): Fields’ Virology. Philadelphia, Lippincott Williams & Wilkins, 2001, vol 1, ed 4, pp 1533–1579.
 
7. Bernstein JM. Treatment of community-acquired pneumonia: IDSA guidelines—Infectious Diseases Society of America. Chest 1999; 115( 3 Suppl): 9S–13S.
 
8. Robertson L, Caley JP, Moore J. Importance of Staphylococcus aureus in pneumonia in the 1957 epidemic of influenza A. Lancet 1958; 2: 233–236.
 
9. Tashiro M, Ciborowski P, Reinacher M, et al. Synergistic role of staphylococcal proteases in the induction of influenza virus pathogenicity. Virology 1987; 157: 421–430.
 
10. Tashiro M, Klenk HD, Rott R. Inhibitory effect of a protease inhibitor, leupeptin, on the development of influenza pneumonia, mediated by concomitant bacteria. J Gen Virol 1987; 68: 2039–2041.
 
11. Aschan J, Ringden O, Ljungman P, et al. Influenza B in transplant patients. Scand J Infect Dis 1989; 21: 349–350.
 
12. Ljungman P, Andersson J, Aschan J, et al. Influenza A in immunocompromised patients. Clin Infect Dis 1993; 17: 244–247.
 
13. Safrin S, Rush JD, Mills J. Influenza in patients with human immunodeficiency virus infection. Chest 1990; 98: 33–37.
 
14. Klimov AI, Rocha E, Hayden FG, et al. Prolonged shedding of amantadine-resistant influenzae A viruses by immunodeficient patients: Detection by polymerase chain reaction-restriction analysis. J Infect Dis 1995; 172: 1352–1355.
 
15. Gubareva LV, Matrosovich MN, Brenner MK, et al. Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus. J Infect Dis 1998; 178: 1257–1262.
 
16. Sherk PA, Grossman RF. The chronic obstructive pulmonary disease exacerbation. Clin Chest Med 2000; 21: 705–721.
 
17. Greenberg SB, Allen M, Wilson J, et al. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162: 167–173.
 
18. Hordvik NL, Konig P, Hamory B, et al. Effects of acute viral respiratory tract infections in patients with cystic fibrosis. Pediatr Pulmonol 1989; 7: 217–222.
 
19. Malhotra A, Krilov LR. Viral croup. Pediatr Rev 2001; 22: 5–12.
 
20. Nichol KL, Margolis KL, Wuorenma J, et al. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994; 331: 778–784.
 
21. Karjalainen J, Nieminen MS, Heikkila J. Influenza A1 myocarditis in conscripts. Acta Med Scand 1980; 207: 27–30.
 
22. Glezen WP, Decker M, Perrotta DM. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978–1981. Am Rev Respir Dis 1987; 136: 550–555.
 
23. Bainton D, Jones GR, Hole D. Influenza and ischaemic heart disease: A possible trigger for acute myocardial infarction? Int J Epidemiol 1978; 7: 231–239.
 
24. Sugaya N, Nerome K, Ishida M, et al. Impact of influenza virus infection as a cause of pediatric hospitalization. J Infect Dis 1992; 165: 373–375.
 
25. Brocklebank JT, Court SD, McQuillin J, et al. Influenza-A infection in children. Lancet 1972; 2: 497–500.
 
26. McCullers JA, Facchini S, Chesney PJ, et al. Influenza B virus encephalitis. Clin Infect Dis 1999; 28: 898–900.
 
27. Kurita A, Furushima H, Yamada H, et al. Periodic lateralized epileptiform discharges in influenza B-associated encephalopathy. Intern Med 2001; 40: 813–816.
 
28. Hurwitz ES, Goodman RA. A cluster of cases of Reye syndrome associated with chickenpox. Pediatrics 1982; 70: 901–906.
 
29. Belay ED, Bresee JS, Holman RC, et al. Reye's syndrome in the United States from 1981 through 1997. N Engl J Med 1999; 340: 1377–1382.
 
30. Trey C, Burns DG, Saunders SJ. Treatment of hepatic coma by exchange blood transfusion. N Engl J Med 1966; 274: 473–481.
 
31. Kindt GW, Waldman J, Kohl S, et al. Intracranial pressure in Reye syndrome: Monitoring and control. JAMA 1975; 231: 822–825.
 
32. Waldman RJ, Hall WN, McGee H, et al. Aspirin as a risk factor in Reye's syndrome. JAMA 1982; 247: 3089–3094.
 
33. Halpin TJ, Holtzhauer FJ, Campbell RJ, et al. Reye's syndrome and medication use. JAMA 1982; 248: 687–691.
 
34. Minow RA, Gorbach S, Johnson BL Jr, et al. Myoglobinuria associated with influenza A infection. Ann Intern Med 1974; 80: 359–361.
 
35. Singh U, Scheld WM. Infectious etiologies of rhabdomyolysis: Three case reports and review. Clin Infect Dis 1996; 22: 642–649.
 
36. Gamboa ET, Eastwood AB, Hays AP, et al. Isolation of influenza virus from muscle in myoglobinuric polymyositis. Neurology 1979; 29: 1323–1335.
 
37. Sperber SJ, Francis JB. Toxic shock syndrome during an influenza outbreak. JAMA 1987; 257: 1086–1087.
 
38. MacDonald KL, Osterholm MT, Hedberg CW, et al. Toxic shock syndrome: A newly recognized complication of influenza and influenzalike illness. JAMA 1987; 257: 1053–1058.